Ardelyx Inc(ARDX-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Sectors & Indices
Sector
Industry
Employees
Profile
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Key Executives
| Name | Title |
|---|---|
| Justin A. Renz | CFO/COO |
| Michael G. Raab | CEO/Director/President |
| David P. Rosenbaum | Other Executive Officer |
| Elizabeth Grammer | Chief Administrative Officer/Chief Legal Officer |
| Susan Rodriguez | Other Executive Officer |
| Robert Blanks | Other Executive Officer |
| Laura Williams | Chief Medical Officer |
| Mike Kelliher | Executive VP, Divisional |